UNQUOTE

NORWAY - Venture-backed Algeta applies for listing

  • TineThoresen
  • LinkedIn  
  • Google plus  

Therapeutics company Algeta ASA has applied for listing on the Oslo Stock Exchange. The company raised NOK 185m in series-A financing from a consortium of investors, including HealthCap, Advent Venture Partners, SR One, and existing investors, Selvaag Venture Capital, NorgesInvestor, Marlin Verdi AS and several smaller investors in 2005. .

Algeta wants to float to accelerate the late-stage clinical development of its lead product and provide a platform for growth

ABG Sundal Collier and DnB NOR Markets have been appointed lead financial advisers and Terra Securities is co-lead manager.

Algeta develops novel and proprietary therapeutics and technologies based on alpha particle emitting radionuclides targeting a broad range of metastatic and disseminated tumors.

  • LinkedIn  
  • Google plus  

More on Exits

Latest News